Workshop 3
ARISE IV 2026
WORKSHOP #3
AMBULATORY NEUROINTERVENTIONAL CARE (ANC): Defining Candidates, Venues and Indications
Location: Dupont
MODERATORS
Elad Levy, University at Buffalo, Buffalo, NY
Dorothea Altschul, St. Joseph’s Health, New Jersey, NY
Ameer E. Hassan, University of Texas, TX
WORKSHOP OUTLINE
- Introduction & Objectives: Goals for defining ANC standards and publication plans.
- Patient Selection: Criteria for identifying ideal candidates for ambulatory care.
- Venue and Infrastructure: Requirements for ASCs vs. office-based labs.
- Indications & Procedures: Specific neurointerventional procedures suited for
- the ambulatory setting.
- Safety & Quality: Protocols for patient safety and outcome monitoring.
- Future Directions: Regulatory hurdles and expansion of ANC.
PARTICIPANTS
- David Altschul – Montefiore Medical Center
- Matthew Amans – University of California
- Mark Bain – Cleveland Clinic
- Brian Bartolomeo – Balt Group
- Elizabeth Baucom – Advocate Health
- Oscar Bolanos – Medtronic
- Linnea Burman – Medtronic
- Marc Camprubi – Navigantis
- Mairsil Claffey – Ceroflo
- Joseph De Croos – Vena Medical
- Chad Evans – Stryker
- Matthew Fitz – Nuvascular Inc.
- Peter Forsythe – J&J MedTech Neurovascular
- Robert Gash – Terumo Neuro
- Mohammad Ghani – NIH
- Jeff Groom – Arsenal Medical
- Martin Harris – Mentice
- Sean Hylton – Nuvascular Inc.
- Ashutosh Jadhav – UTHealth Houston / Memorial Hermann Health System
- Chris Kellner – Mount Sinai Health System
- Jared Knopman – Weill Cornell Medicine
- Jonathan Lee – Medtronic
- Subu Mangipudi – Medtronic
- Jim Marucci – Stryker
- Patrick Noonan – FDA
- Michael Phillips – Vena Medical
- Brandon Shepard – Balt Group
- Kevin Steed – Stryker
- Sara Thompson – FDA
- Mathias Unberath – John Hopkins University
- Brock Vendsel – Medtronic
- Joe Woo – Siemens Healthineers